Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0HC7.L
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 93.78 2.84 1.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1932.31 -92.92 -4.57
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 22.43 98.19 80.20
Cash 130.83 17.50 7.58
Capex 15.38 -4.93 -5.83
Free Cash Flow 38.52 -4.10 -6.67
Revenue -42.30 11.59 20.08
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -90.97 0.03 -0.29
Operating Margin 72.11 -0.11 -0.38
ROA -99.62 < 0.005 -0.03
ROE -99.68 < 0.005 -0.07
ROIC 87.43 < 0.005 -0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0HC7.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0HC7.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0HC7.L is permitted for members.